Milford have owned Neuren Pharmaceuticals since October 2007.In the past they supported capital raisings in June 2020 and September 2021 and announced a substantial shareholder position in December 2021 with a 5.2% shareholding.
It does appear that Milford have now taken some profit off the table and reduced their current stock holdings of 6.2% back to the December 2021 substantial shareholder position of 5.2%.
Kens
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.90 |
Change
-0.060(0.46%) |
Mkt cap ! $1.602B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.02 | $12.70 | $949.4K | 73.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 564 | $12.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.91 | 1803 | 8 |
View Market Depth
| Last trade - 10.53am 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |